ZAETHER and QBDVision Announce New Strategic Collaboration
Mansfield, MA — October 23, 2023 — ZAETHER, the leading digital enabler for organizations developing and manufacturing biotech products, and QbDVision, the leading Digital CMC platform for data-driven drug development, have announced a strategic collaboration to help pharma and biotech companies modernize across the drug product value chain and achieve unparalleled efficiency, speed, and compliance. The partnership combines QbDVision's innovative software solution for managing product and process knowledge with ZAETHER's digital design, integration, and adoption expertise. Together, they aim to address the biggest challenge in the industry's information ecosystem: inefficient process and knowledge transfer throughout the process development and manufacturing lifecycle.
ZAETHER's approach to a hyper-connected, state-of-the-art enterprise includes incorporating solutions such as QBDVision's breakthrough CMC (Chemistry, Manufacturing, and Controls) digital playbook and platform into their recommended strategies and designs.
An initial focus of the collaboration between the two companies is the transition between process development and manufacturing execution. John Seffernick, ZAETHER’s Managing Director, announced that “One of the first goals of our partnership is to show that it’s possible to break that persistent bottleneck to create a truly efficient, digital-first approach to transitioning new drug products from process development to commercial-scale manufacturing.”
Yash Sabharwal, President and CEO of QbDVision, followed: “For a lot of drug developers and CDMOs, tech transfers are one of those challenges that everyone just accepts. They’re assumed to be time-consuming and expensive, with a significant margin for error. At QbDVision and ZAETHER,” he added, “we don’t accept that.”
Yash continued: “Digitalization coupled with a structured data framework that aligns to commercialization phases, activities, and information can bring significant efficiencies, lowering the overall costs of tech transfer and getting therapies and vaccines to the market faster.”
For more information about this transformative collaboration or to discuss your tech transfer challenges, please contact ZAETHER at zaether.com/get-started.
ZAETHER is the leading digital enabler for organizations developing and manufacturing next-gen biotech products. Combining knowledge of the industry landscape with an understanding of people and workflows, ZAETHER creates hyper-connected biotech organizations that can bring their cutting-edge innovations to people faster and more efficiently.
QBDVision is the first modern digital CMC workspace: a cloud-based SaaS solution designed to enhance the curation, utilization, and integrity of process development data to accelerate therapies to patients. Developed by a world-class team of drug development experts, QbDVision provides a structured digital framework for integrating CMC workflows, embedding best practices for process design, and managing product and process knowledge.